Global Revenue Of Cholesterol Testing Services Market Is About USD 17.57 billion USD In 2021



 Cholesterol is a waxy, fat-like molecule found in all of our body's cells. When you have too much cholesterol in your blood, it can interact with other molecules to produce plaque, which adheres to the artery walls. A lipid panel or lipid profile is another name for a full cholesterol test. It can be used by your doctor to determine the quantity of “good” and “bad” cholesterol as well as triglycerides (a form of fat) in your blood.

From an estimated value of USD 11.96 billion in 2016, the global cholesterol testing services market is predicted to reach USD 17.57 billion by 2021, increasing at a CAGR of 8% over the forecast period. Factors such as the rising incidence of cardiovascular diseases and obesity, physicians' preference for laboratory testing over self-testing, government initiatives to improve testing quality, and the rapid growth of the geriatric population are propelling the growth of the cholesterol testing market. However, the quick expansion of home/self-testing and the introduction of noninvasive cholesterol testing methods are two important issues that could limit the market's growth.

The cholesterol testing market is divided into two categories: client type and geographic location. Physicians/providers and hospitals; employers, health plans, and Managed Care Organizations (MCOs); government agencies, Accountable Care Organizations (ACOs), and Integrated Delivery Networks (IDNs); and patients are the different types of customers in the market. In order to deliver reliable and up-to-date diagnostic information to their clients, companies in the market are developing novel products. Quest Diagnostics (US) introduced QuestDirect, a new patient-initiated testing service, in November 2016.

The cholesterol testing services market is divided into four regions: North America, Europe, Asia, and Rest of the World. In 2016, North America is predicted to dominate the worldwide cholesterol testing market, with the United States accounting for a significant portion of the market. During the projection period, Asia is expected to be the fastest-growing region in terms of CAGR. This is due to the Asian region's enormous population, rising prevalence of cardiovascular disorders, and growing number of testing facilities.

Laboratory Corporation of America Holdings (LabCorp) (US), Quest Diagnostics Incorporated (US), Eurofins Scientific (Luxembourg), Spectra Laboratories Inc. (US), Unilabs (Switzerland), SYNLAB International GmbH (Germany), Bio-Reference Laboratories Inc. (US), Clinical Reference Laboratory, Inc. (CRL) (US), ACM Medical Laboratory (US) are some of the major players in the cholesterol testing market (China).

Comments

Popular posts from this blog

Quaternary Ammonium Compounds Market to Grow at USD 1.63 billion by 2027: COVID Impact & Post COVID Analysis, Business Opportunities, and Strategies

Butyraldehyde Market Trends, Growth, Demand, opportunities, Scope & Forecast 2027 by CMI

Glass Mat Thermoplastic Market : Size, Growth, Regional Analysis, And Market Area